• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Viruses . Development of a Hamster Natural Transmission Model of SARS-CoV-2 Infection

tetano

Editor, Senior Moderator
Viruses


. 2021 Nov 9;13(11):2251.
doi: 10.3390/v13112251.
Development of a Hamster Natural Transmission Model of SARS-CoV-2 Infection


Stuart Dowall[SUP] 1 [/SUP], Francisco J Salguero[SUP] 1 [/SUP], Nathan Wiblin[SUP] 1 [/SUP], Susan Fotheringham[SUP] 1 [/SUP], Graham Hatch[SUP] 1 [/SUP], Simon Parks[SUP] 1 [/SUP], Kathryn Gowan[SUP] 1 [/SUP], Debbie Harris[SUP] 1 [/SUP], Oliver Carnell[SUP] 1 [/SUP], Rachel Fell[SUP] 1 [/SUP], Robert Watson[SUP] 1 [/SUP], Victoria Graham[SUP] 1 [/SUP], Karen Gooch[SUP] 1 [/SUP], Yper Hall[SUP] 1 [/SUP], Simon Mizen[SUP] 2 [/SUP], Roger Hewson[SUP] 1 [/SUP]



Affiliations

Abstract

The global pandemic of coronavirus disease (COVID-19) caused by infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has led to an international thrust to study pathogenesis and evaluate interventions. Experimental infection of hamsters and the resulting respiratory disease is one of the preferred animal models since clinical signs of disease and virus shedding are similar to more severe cases of human COVID-19. The main route of challenge has been direct inoculation of the virus via the intranasal route. To resemble the natural infection, we designed a bespoke natural transmission cage system to assess whether recipient animals housed in physically separate adjacent cages could become infected from a challenged donor animal in a central cage, with equal airflow across the two side cages. To optimise viral shedding in the donor animals, a low and moderate challenge dose were compared after direct intranasal challenge, but similar viral shedding responses were observed and no discernible difference in kinetics. The results from our natural transmission set-up demonstrate that most recipient hamsters are infected within the system developed, with variation in the kinetics and levels of disease between individual animals. Common clinical outputs used for the assessment in directly-challenged hamsters, such as weight loss, are less obvious in hamsters who become infected from naturally acquiring the infection. The results demonstrate the utility of a natural transmission model for further work on assessing the differences between virus strains and evaluating interventions using a challenge system which more closely resembles human infection.

Keywords: COVID-19; animals; transmission.
 
Back
Top Bottom